1 |
Liu FT , Ge JJ , Wu JJ , Wu P , Ma Y , Zuo CT , Wang J . Clinical, dopaminergic, and metabolic correlations in Parkinson disease: a dual-tracer PET study. Clin Nucl Med, 2018, 43: 562- 571.
doi: 10.1097/RLU.0000000000002148
|
2 |
Seiffert AP , Gómez-Grande A , Alonso-Gómez L , Méndez-Guerrero A , Villarejo-Galende A , Gómez EJ , Sánchez-GonzálezP . Differences in striatal metabolism in. Diagnostics (Basel), 2022, 13: 6.
doi: 10.3390/diagnostics13010006
|
3 |
Golan H , Volkov O , Shalom E . Nuclear imaging in Parkinson's disease: the past, the present, and the future. J Neurol Sci, 2022, 436: 120220.
doi: 10.1016/j.jns.2022.120220
|
4 |
Peralta C , Biafore F , Depetris TS , Bastianello M . Recent advancement and clinical implications of 18FDG-PET in Parkinson's disease, atypical parkinsonisms, and other movement disorders. Curr Neurol Neurosci Rep, 2019, 19: 56.
doi: 10.1007/s11910-019-0966-3
|
5 |
Tolosa E , Garrido A , Scholz SW , Poewe W . Challenges in the diagnosis of Parkinson's disease. Lancet Neurol, 2021, 20: 385- 397.
doi: 10.1016/S1474-4422(21)00030-2
|
6 |
Sun J , Cong C , Li X , Zhou W , Xia R , Liu H , Wang Y , Xu Z , Chen X . Identification of Parkinson's disease and multiple system atrophy using multimodal PET/MRI radiomics. Eur Radiol, 2024, 34: 662- 672.
|
7 |
Ruppert MC , Greuel A , Tahmasian M , Schwartz F , Stürmer S , Maier F , Hammes J , Tittgemeyer M , Timmermann L , van Eimeren T , Drzezga A , Eggers C . Network degeneration in Parkinson's disease: multimodal imaging of nigro-striato-cortical dysfunction. Brain, 2020, 143: 944- 959.
doi: 10.1093/brain/awaa019
|
8 |
Meles SK , Oertel WH , Leenders KL . Circuit imaging biomarkers in preclinical and prodromal Parkinson's disease. Mol Med, 2021, 27: 111.
|
9 |
Shen B , Wei S , Ge J , Peng S , Liu F , Li L , Guo S , Wu P , Zuo C , Eidelberg D , Wang J , Ma Y . Reproducible metabolic topographies associated with multiple system atrophy: network and regional analyses in Chinese and American patient cohorts. Neuroimage Clin, 2020, 28: 102416.
doi: 10.1016/j.nicl.2020.102416
|
10 |
Grimaldi S , Boucekine M , Witjas T , Fluchère F , Renaud M , Azulay JP , Guedj E , Eusebio A . Multiple system atrophy: phenotypic spectrum approach coupled with brain 18-FDG PET. Parkinsonism Relat Disord, 2019, 67: 3- 9.
doi: 10.1016/j.parkreldis.2019.09.005
|
11 |
Zhao P , Zhang B , Gao S , Li X . Clinical features, MRI, and 18F-FDG-PET in differential diagnosis of Parkinson disease from multiple system atrophy. Brain Behav, 2020, 10: e01827.
doi: 10.1002/brb3.1827
|
12 |
Parkinson's Disease and Movement Disorders Group, Neurology Branch, Chinese Medical Association , Parkinson's Disease and Movement Disorders Committee, Neurologist Branch, Chinese Medical Doctor Association . Diagnostic criteria for Parkinson's disease in China (2016 edition). Zhonghua Shen Jing Ke Za Zhi, 2016, 49: 268- 271.
doi: 10.3760/cma.j.issn.1006-7876.2016.04.002
|
|
中华医学会神经病学分会帕金森病及运动障碍学组, 中国医师协会神经内科医师分会帕金森病及运动障碍专业委员会. 中国帕金森病的诊断标准(2016版). 中华神经科杂志, 2016, 49: 268- 271.
doi: 10.3760/cma.j.issn.1006-7876.2016.04.002
|
13 |
Wenning GK , Stankovic I , Vignatelli L , Fanciulli A , Calandra-Buonaura G , Seppi K , Palma JA , Meissner WG , Krismer F , Berg D , Cortelli P , Freeman R , Halliday G , H glinger G , Lang A , Ling H , Litvan I , Low P , Miki Y , Panicker J , Pellecchia MT , Quinn N , Sakakibara R , Stamelou M , Tolosa E , Tsuji S , Warner T , Poewe W , Kaufmann H . The Movement Disorder Society criteria for the diagnosis of multiple system atrophy. Mov Disord, 2022, 37: 1131- 1148.
doi: 10.1002/mds.29005
|
14 |
Stebbins GT , Goetz CG , Burn DJ , Jankovic J , Khoo TK , Tilley BC . How to identify tremor dominant and postural instability/gait difficulty groups with the movement disorder society unified Parkinson's disease rating scale: comparison with the unified Parkinson's disease rating scale. Mov Disord, 2013, 28: 668- 670.
doi: 10.1002/mds.25383
|
15 |
Minoshima S , Frey KA , Koeppe RA , Foster NL , Kuhl DE . A diagnostic approach in Alzheimer's disease using three-dimensional stereotactic surface projections of fluorine-18-FDG PET. J Nucl Med, 1995, 36: 1238- 1248.
|
16 |
Lindstr m E , Oddstig J , Danfors T , J gi J , Hansson O , Lubberink M . Image reconstruction methods affect software-aided assessment of pathologies of [18F]flutemetamol and [18F] FDG brain-PET examinations in patients with neurodegenerative diseases. Neuroimage Clin, 2020, 28: 102386.
doi: 10.1016/j.nicl.2020.102386
|
17 |
McKay JH , Cheshire WP . First symptoms in multiple system atrophy. Clin Auton Res, 2018, 28: 215- 221.
doi: 10.1007/s10286-017-0500-0
|
18 |
Postuma RB , Berg D , Stern M , Poewe W , Olanow CW , Oertel W , Obeso J , Marek K , Litvan I , Lang AE , Halliday G , Goetz CG , Gasser T , Dubois B , Chan P , Bloem BR , Adler CH , Deuschl G . MDS clinical diagnostic criteria for Parkinson's disease. Mov Disord, 2015, 30: 1591- 1601.
doi: 10.1002/mds.26424
|
19 |
Wu JW , Lan XL , Wang T . The application of molecular imaging in Parkinson's disease. Zhonghua Shen Jing Ke Za Zhi, 2021, 54: 751- 757.
doi: 10.3760/cma.j.cn113694-20210210-00109
|
|
吴佳薇, 兰晓莉, 王涛. 分子影像技术在帕金森病诊断及鉴别诊断中的临床应用. 中华神经科杂志, 2021, 54: 751- 757.
doi: 10.3760/cma.j.cn113694-20210210-00109
|
20 |
Akdemir ࢬ Ö , Bora Tokç aer A , Atay LÖ . Dopamine transporter SPECT imaging in Parkinson's disease and parkinsonian disorders. Turk J Med Sci, 2021, 51: 400- 410.
doi: 10.3906/sag-2008-253
|
21 |
Pagano G , Niccolini F , Politis M . Imaging in Parkinson's disease. Clin Med (Lond), 2016, 16: 371- 375.
|
22 |
Wang J , Ma Y , Huang Z , Sun B , Guan Y , Zuo C . Modulation of metabolic brain function by bilateral subthalamic nucleus stimulation in the treatment of Parkinson's disease. J Neurol, 2010, 257: 72- 78.
doi: 10.1007/s00415-009-5267-3
|
23 |
Saeed U , Lang AE , Masellis M . Neuroimaging advances in Parkinson's disease and atypical parkinsonian syndromes. Front Neurol, 2020, 11: 572976.
doi: 10.3389/fneur.2020.572976
|
24 |
Dickson DW . Neuropathology of Parkinson disease. Parkinsonism Relat Disord, 2018, 46 Suppl 1 (Suppl 1): S30- S33.
|
25 |
Jellinger KA . Neuropathology of multiple system atrophy: new thoughts about pathogenesis. Mov Disord, 2014, 29: 1720- 1741.
doi: 10.1002/mds.26052
|
26 |
Houssein NJ , Henriksen AC , Hejl AM , Marner L . Diagnostic accuracy of cerebral [18F]FDG PET in atypical parkinsonism[J].FDG-PET in differential diagnosis of Parkinson disease from multiple system atrophy. EJNMMI Res, 2023, 13: 74.
doi: 10.1186/s13550-023-01025-x
|
27 |
Gu SC , Ye Q , Yuan CX . Metabolic pattern analysis of 18F-FDG PET as a marker for Parkinson's disease: a systematic review and meta-analysis. Rev Neurosci, 2019, 30: 743- 756.
doi: 10.1515/revneuro-2018-0061
|
28 |
Meyer PT , Frings L , Rücker G , Hellwig S . 18F-FDG PET in parkinsonism: differential diagnosis and evaluation of cognitive impairmen. J Nucl Med, 2017, 58: 1888- 1898.
doi: 10.2967/jnumed.116.186403
|